Oral Antiviral Pill Therapy

Avant Pharmacy & Wellness Center can now provide patients an oral antiviral pill therapy for the treatment of COVID-19 in patients who are experiencing mild to moderate symptoms. While the FDA has granted Emergency Use Authorization of this medication, it is recommended for patients:

  • with positive results of direct SARS-CoV-2 viral testing, and
  • who are at high risk for progressing to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate

This is not for pre or post exposure. Treatment should be initiated within 5 days of symptom onset.

Not recommended for use during pregnancy. Assess whether patients with child-bearing are pregnant before initiation of therapy.

  • Females: Reliable form of birth control should be used during treatment AND four days after final dose
  • Males: Should use reliable form of contraception during treatment AND three months after final dose

Patient will be pre-screened to determine eligibility. Below are a list of conditions that may put patients at “HIGH-RISK” for progressing to severe COVID-19:

  • Aged ≥ 60 years
  • Being overweight (BMI 25+)
  • Smokers (Current, Former)
  • Diabetes
  • High Blood Pressure
  • Cardiovascular disease (including congenital heart disease)
  • Chronic lung diseases (e.g., asthma, chronic obstructive pulmonary disease, interstitial lung disease, cystic fibrosis, pulmonary hypertension)
  • Vitamin D deficiency
  • An immunocompromising condition or immunosuppressive treatment
  • Chronic kidney disease
  • Sickle cell disease
  • Neurodevelopmental disorders (e.g., cerebral palsy) or other conditions that confer medical complexity (e.g., genetic or metabolic syndromes and severe congenital anomalies)
  • Medical-related technological dependence (e.g., tracheostomy, gastrostomy, or positive pressure ventilation that is not related to COVID-19)
  • Mental Health Conditions (Depression, Schizophrenia)
  • History of Substance abuse (alcohol, drugs)
  • History of Stroke
PLEASE NOTE:   At this point in time, supply is extremely limited, so prescriptions for oral COVID-19 treatment will not be filled until we speak to the patient/caregiver to confirm eligibility. Patients will be called in the order in which prescriptions are received and oral therapeutics will be filled in the order in which we speak to patients. All patients will be provided with a copy of the Patient EUA Fact Sheet, and every course will be tagged “Do not dispense after XX date” to prevent dispensing outside of the 5-day treatment window. We will enforce contactless dispensing of COVID therapeutics, so please plan to use our drive-thru or to call us to schedule a delivery or if they have any questions at 704-537-0909